Skip to main content

Table 1 Demographic and biochemical characteristics of the study groups

From: Serum prolidase activity and oxidant–antioxidant status in children with chronic hepatitis B virus infection

 

Chronic hepatitis B(a)(n = 38)

Inactive hepatitis B(b)(n = 31)

Controls(c)(n = 29)

p

Age, years

11.4 ± 3.6

12.2 ± 2.7

11.3 ± 2.7

a-b-cNS

BMI, z-scores

−0.156 ± 1.011

−0.134 ± 0.998

0.240 ± 0.698

a-b-cNS

Serum glucose (mg/d L)

93.6 ± 9.1

93.0 ± 11.7

96.4 ± 14.5

a-b-cNS

Serum ALB (g/dL)

3.0 ± 0.3

4.0 ± 0.3

4.0 ± 0.2

a-b-cNS

TBIL (mg/dL)

0.65 ± 0.93

0.59 ± 0.39

0.41 ± 0.16

a-b-cNS

ALT (IU/L)

73.6 ± 64.8*

28.5 ± 12.9

24.9 ± 6.6

a-b < 0.001, a-c < 0.001, b-cNS, a-b-c < 0.001

AST (IU/L)

59.9 ± 53.6

27.8 ± 8.3

25.9 ± 5.8

a-b < 0.001, a-c < 0.001, b-cNS, a-b-c < 0.001

GGT (IU/L)

35.9 ± 47.8

18.5 ± 9.9

18.9 ± 6.1

a-b-cNS

aPTT (second)

28.58 ± 3.23

31.10 ± 11.46

34.58 ± 15.72

a-b-cNS

INR

1.09 ± 0.07

1.06 ± 0.08

1.05 ± 0.06

a-b-cNS

  1. Data presented as mean ± standard deviation, * p < 0.001vs. inactive hepatitis B and controls.
  2. BMI, body mass index; ALB, albumin; TBIL, total bilirubin, ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, GGT: Gamma glutamyl transferase, INR: International normalized ratio of prothrombin time; and aPTT: Activated partial thromboplastin time, NS: Not significant.